Premature Rupture of Mambrane and Unfavourable Cervix
Primary Purpose
Cervix; Insufficient Dilatation in Labor
Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
COOK RIPENENIG BALLOON+PITOCN
PITOCIN
double balloonand oxytocin
ballon and oxytocin
double balloonand and oxytocin
Sponsored by
About this trial
This is an interventional treatment trial for Cervix; Insufficient Dilatation in Labor
Eligibility Criteria
Inclusion Criteria:
- Diagnosed to be pregnant with PROM at > 34 week
- Found to have a Bishop score of 4 points or less.
- Diagnosed as having a singleto
- Willingness to comply with the protocol for the duration of the study.
- Have signed an informed consent.
Exclusion Criteria:
- Any contraindication for a vaginal deliver
- Regular uterine contractn
- Evidence of chorio-amonitis
- Previous cesarean section or presence of any uterine scar.
- Suspected placental abruption or presence of a significant hemorrhage.
- Non-reassuring fetal statu
Sites / Locations
- Hillel Yaffe Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
GROUP 1: Oxytocin infusion alone
double balloonand oxytocin
Arm Description
GROUP 1: Oxytocin infusion alone
insertion of the double balloon and oxytocin
Outcomes
Primary Outcome Measures
PPROM/PROM to delivery interval
Time from rupture of mambrane to delivery
From hospitalization until delivery
Secondary Outcome Measures
Full Information
NCT ID
NCT01615107
First Posted
April 23, 2012
Last Updated
June 6, 2012
Sponsor
Hillel Yaffe Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT01615107
Brief Title
Premature Rupture of Mambrane and Unfavourable Cervix
Official Title
Comparison Between the Use of Standard Oxytocin Induction Protocol and the Double-balloon Catheter Device With Concurrent Oxytocin
Study Type
Interventional
2. Study Status
Record Verification Date
April 2012
Overall Recruitment Status
Unknown status
Study Start Date
July 2012 (undefined)
Primary Completion Date
July 2014 (Anticipated)
Study Completion Date
July 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hillel Yaffe Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The paucity of published data concerning the issue of mechanical labor induction in the setting of Term PROM has led us to undertake the present clinical trial. This study is designed to compare the efficacy and safety of the standard Oxytocin induction protocol with the double-balloon catheter device with concurrent oxytocin administration in patients with Term PROM and unfavorable cervical conditions.
Detailed Description
This will be a prospective randomised trial. Two hundred pregnant women with term PROM and an unfavourable cervix (Bishop Score ≤ 4) are expected to be entered into the study (see statistical analysis below).
All eligible women will be presented with the study protocol by a study coordinator. Women interested in participating will read and sign the informed consent. Subsequently, the following screening medical procedures will be completed: medical and gynecological history, physical and vaginal examination, ultrasonography to: (i) Confirm fetal vertex presentation, (ii) Exclude placenta previa and (iii) Assess cervical length and posterior cervical angle. (iv) Asses bio-physical profile score
A non-stress test will be performed in order to monitor:
The fetal heart pattern for the presence or absence of decelerations and
The presence of uterine contractions. All women will undergo a pelvic examination by a staff member to obtain an initial Bishop score.
If the patient will be determined eligible for study entry, and following the informed consent, randomisation into the following groups will take place:
GROUP 1: Oxytocin infusion alone (Standard Protocol). GROUP 2: insertion of the double balloon device and concurrent oxytocin administration.
GROUP 3: Expectant management
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervix; Insufficient Dilatation in Labor
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
GROUP 1: Oxytocin infusion alone
Arm Type
Experimental
Arm Description
GROUP 1: Oxytocin infusion alone
Arm Title
double balloonand oxytocin
Arm Type
Experimental
Arm Description
insertion of the double balloon and oxytocin
Intervention Type
Device
Intervention Name(s)
COOK RIPENENIG BALLOON+PITOCN
Other Intervention Name(s)
BALLOON+PITOCN
Intervention Description
GROUP 2: insertion of the double balloon device and concurrent oxytocin administration.
Intervention Type
Drug
Intervention Name(s)
PITOCIN
Other Intervention Name(s)
Oxytocin infusion alone
Intervention Description
: Oxytocin infusion alone (Standard Protocol
Intervention Type
Other
Intervention Name(s)
double balloonand oxytocin
Other Intervention Name(s)
balloonand oxytocin
Intervention Description
balloonand oxytocin
Intervention Type
Other
Intervention Name(s)
ballon and oxytocin
Other Intervention Name(s)
balloon catheter device with concurrent oxytocin
Intervention Description
double- balloon catheter device with concurrent oxytocin
Intervention Type
Procedure
Intervention Name(s)
double balloonand and oxytocin
Other Intervention Name(s)
balloon catheter device with concurrent oxytocin
Intervention Description
balloon catheter device with concurrent oxytocin
Primary Outcome Measure Information:
Title
PPROM/PROM to delivery interval
Description
Time from rupture of mambrane to delivery
From hospitalization until delivery
Time Frame
3year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Diagnosed to be pregnant with PROM at > 34 week
Found to have a Bishop score of 4 points or less.
Diagnosed as having a singleto
Willingness to comply with the protocol for the duration of the study.
Have signed an informed consent.
Exclusion Criteria:
Any contraindication for a vaginal deliver
Regular uterine contractn
Evidence of chorio-amonitis
Previous cesarean section or presence of any uterine scar.
Suspected placental abruption or presence of a significant hemorrhage.
Non-reassuring fetal statu
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elad Mei-Dan, Dr
Phone
972-4-6188243
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elad Mei-Dan, DR
Organizational Affiliation
Hillel Yaffe Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hillel Yaffe Medical Center
City
Hadera
ZIP/Postal Code
38101
Country
Israel
Facility Contact:
First Name & Middle Initial & Last Name & Degree
HILLEL YAFFE MEDICAL CENTER
First Name & Middle Initial & Last Name & Degree
ELAD MEI-DAN, M.D.
12. IPD Sharing Statement
Learn more about this trial
Premature Rupture of Mambrane and Unfavourable Cervix
We'll reach out to this number within 24 hrs